Fundamentals for DuPont de Nemours, Inc.
A recent buy bias from analysts toward DuPont de Nemours, Inc. may inspire confidence in investors, who could view the stock as a promising investment. This positive sentim...
Business Operations:
Sector: Basic MaterialsIndustry: Specialty Chemicals
DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. It operates through two segments, Healthcare & Water Technologies and Diversified Industrials. The company offers specialty components for medical devices, packaging and garments, and protective suits under the brand TYVEK; provides water filtration and separation solutions, including elements, modules, and systems serving primarily industrial wastewater and energy markets, municipal and desalination applications, and life sciences and specialty sectors. It also offers AMBERLITE ion exchange resins, FILMTEC reverse osmosis and nanofiltration elements, and INGE and ITEGRATEC ultrafiltration modules. In addition, the company offers engineered products and integrated solutions for the non-residential, residential, and repair-and-remodel construction markets, includes TYVEK house wrap, STYROFOAM insulation, and CORIAN solid surface. Further, it engages in the design and production of engineered components, systems, and process solutions used in OEM and operational applications, such as automotive, aerospace, printing, and packaging. Additionally, the company offers Vespel shapes and parts, MOLYKOTE specialty lubricants, BETAFORCE and BETASEAL structural adhesives, and Cyrel flexographic printing plates. The company was formerly known as DowDuPont Inc. and changed its name to DuPont de Nemours, Inc. in June 2019. DuPont de Nemours, Inc. was incorporated in 2015 and is headquartered in Wilmington, Delaware.
Revenue projections:
Financial Ratios:
| currentRatio | 2.356000 |
|---|---|
| forwardPE | 18.926626 |
| debtToEquity | 23.229000 |
| earningsGrowth | 0.000000 |
| revenueGrowth | 0.041000 |
| grossMargins | 0.354910 |
| operatingMargins | 0.143890 |
| trailingEps | 2.870000 |
| forwardEps | 8.173670 |
DD's current ratio 2.356, suggesting the company has sufficient liquidity to service its short-term debt. With its cash reserves and current assets in good shape, DD can comfortably meet its immediate liabilities, reflecting a healthy financial standing.
DD's Forward PE being in a reasonable range suggests the stock is fairly priced based on its earnings. The stock isn't overpriced, leaving room for growth, making it an attractive investment for those seeking opportunities for future value appreciation.
DuPont de Nemours, Inc.'s low Debt-to-Equity ratio indicates that the company isn't heavily dependent on debt financing. This lower leverage reduces financial risk and enhances stability, showing that DuPont de Nemours, Inc. is well-positioned to manage its obligations without the burden of excessive debt.
DuPont de Nemours, Inc.'s forward EPS exceeding its trailing EPS implies that the company is projected to be more profitable this year. This suggests an improvement in financial performance, with analysts expecting DuPont de Nemours, Inc. to generate stronger earnings compared to the previous financial year.
Price projections:
Insider Transactions:
DuPont de Nemours, Inc. stock was sold in 6 transactions, with market price at 75.55404345194499.There were no sell transactions during the given period.More buys than sells have been occurring around the current price levels of DuPont de Nemours, Inc., potentially signaling investor optimism. This buying trend might be interpreted as a sign of a favorable outlook for the stock's future performance.
Recommendation changes over time:
A recent buy bias from analysts toward DuPont de Nemours, Inc. may inspire confidence in investors, who could view the stock as a promising investment. This positive sentiment suggests that DuPont de Nemours, Inc. might be an appealing option for those looking to grow their wealth through stock market investments.